tradingkey.logo

Prenetics Global Ltd

PRE
19.240USD
+1.530+8.64%
종가 02/06, 16:00ET시세는 15분 지연됩니다
248.08M시가총액
손실P/E TTM

Prenetics Global Ltd

19.240
+1.530+8.64%

자세한 내용은 Prenetics Global Ltd 회사

Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.

Prenetics Global Ltd 정보

종목 코드 PRE
회사 이름Prenetics Global Ltd
상장일Jul 06, 2021
CEOKwok (Samantha)
직원 수285
유형Ordinary Share
회계 연도 종료Jul 06
주소Unit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
도시
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Hong Kong
우편 번호- -
전화85222109588
웹사이트https://ir.prenetics.com/
종목 코드 PRE
상장일Jul 06, 2021
CEOKwok (Samantha)

Prenetics Global Ltd의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Mr. Hoi Chun (Stephen) Lo
Mr. Hoi Chun (Stephen) Lo
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--
Dr. Yung Ho (Peter) Wong
Dr. Yung Ho (Peter) Wong
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Joel Neoh
Mr. Joel Neoh
Chief Consumer Officer, Chief Executive Officer of CircleDNA
Chief Consumer Officer, Chief Executive Officer of CircleDNA
--
--
Ms. Kathryn Henry
Ms. Kathryn Henry
Independent Director
Independent Director
--
--
Mr. David Vanderveen
Mr. David Vanderveen
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Mr. Hoi Chun (Stephen) Lo
Mr. Hoi Chun (Stephen) Lo
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
Hong Kong
14.27M
46.59%
Taiwan
7.09M
23.16%
The United States
5.51M
18.00%
United Kingdom
2.78M
9.08%
Rest of the world
972.00K
3.17%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Wed, Feb 4
마지막 업데이트: Wed, Feb 4
주주
주주 유형
주주
주주
비율
Dennis (Lo Yuk Ming)
7.69%
Genetel Bioventures Ltd
4.90%
Lawrence (Tzang Chi Hung)
4.29%
Eastspring Investments (Singapore) Limited
3.42%
Aspex Management (HK) Limited
2.76%
기타
76.94%
주주
주주
비율
Dennis (Lo Yuk Ming)
7.69%
Genetel Bioventures Ltd
4.90%
Lawrence (Tzang Chi Hung)
4.29%
Eastspring Investments (Singapore) Limited
3.42%
Aspex Management (HK) Limited
2.76%
기타
76.94%
주주 유형
주주
비율
Individual Investor
13.28%
Corporation
4.90%
Investment Advisor
3.82%
Hedge Fund
2.97%
Research Firm
2.63%
Investment Advisor/Hedge Fund
0.08%
기타
72.32%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
24
1.19M
9.52%
-1.35M
2025Q3
23
1.16M
9.26%
-1.28M
2025Q2
30
3.73M
32.59%
-1.27M
2025Q1
31
3.72M
35.24%
-295.48K
2024Q4
35
3.71M
34.90%
-336.29K
2024Q3
37
3.69M
34.65%
-448.54K
2024Q2
38
3.76M
35.34%
-535.47K
2024Q1
88
5.56M
55.93%
+1.27M
2023Q4
94
4.17M
42.91%
+30.90K
2023Q3
99
4.01M
43.06%
+108.37K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Dennis (Lo Yuk Ming)
962.96K
7.69%
--
--
Apr 24, 2025
Genetel Bioventures Ltd
613.79K
4.9%
--
--
Sep 30, 2024
Lawrence (Tzang Chi Hung)
537.10K
4.29%
--
--
Apr 24, 2025
Eastspring Investments (Singapore) Limited
427.96K
3.42%
--
--
Sep 30, 2025
Aspex Management (HK) Limited
346.15K
2.76%
--
--
Sep 30, 2025
Nomura Securities Co., Ltd.
317.00K
2.53%
-4.83K
-1.50%
Sep 30, 2025
Chun (Lo Hoi)
162.62K
1.3%
--
--
Apr 24, 2025
Renaissance Technologies LLC
26.22K
0.21%
+26.22K
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
21.48K
0.17%
-1.26K
-5.56%
Sep 30, 2025
Stevens Capital Partners
17.38K
0.14%
--
--
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Micro-Cap ETF
0.03%
iShares Micro-Cap ETF
비율0.03%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
날짜
배당락일
유형
비율
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
KeyAI